ArticlePreventive medicine reports2021

A health economic model to estimate the costs and benefits of an mRNA vs DNA high-risk HPV assay in a hypothetical HPV primary screening algorithm in Ontario, Canada.

Georgie Weston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.